Rising demand for personalized medicine is creating new opportunities in the CLL Market. Treatment strategies based on individual patient characteristics are helping healthcare providers improve therapeutic outcomes. Market Overview The Chronic Lymphocytic Leukemia Market was valued at US$ 10.20 billion in 2025 and is expected to reach US$ 14.58 billion by 2034, registering a CAGR of 4.05%...